查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1933277

数位病理市场规模、占有率、成长及全球产业分析：依类型、应用和地区划分的洞察，预测（2026-2034 年）

Digital Pathology Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 149 Pages | 商品交期: 请询问到货日

价格

数位病理市场成长驱动因素

受慢性病发病率上升、住院人数增加以及传统病理工作流程中数位化工具的广泛应用等因素的推动，全球数位病理市场正经历快速增长。数位病理利用全切片扫描仪和数位显微镜创建数位切片，然后使用高通量演算法进行分析，远端共享并储存以供将来参考。 这些创新正在改变现代诊断，在减轻病理学家工作量的同时，实现更快、更准确的分析。

根据 Fortune Business Insights 的数据显示，2025 年该市场价值 13 亿美元，预计 2026 年将成长至 14.7 亿美元，到 2034 年将达到 57.5 亿美元。这意味着 2026 年至 2034 年的复合年增长率 (CAGR) 为 18.56%。北美在 2025 年占市场主导地位，市占率达 36.74%，这得益于其强大的数位基础设施、早期采用人工智慧驱动的病理诊断解决方案以及对先进诊断技术的高度认知。在美国，受 FDA 支持数位化以及远端审查和分析数位切片政策的推动，预计到 2032 年，数位病理市场规模将达到 13 亿美元。

市场驱动因素

慢性病发病率上升：慢性病发病率和住院率的上升推动了对快速、准确的病理检测的需求。研究表明，数位化提高了效率，病理学家报告称，与传统工作流程相比，生产力提高了 15%。此外，数位平台在预测分析和帕金森氏症等疾病的早期诊断方面的应用日益广泛，进一步推动了市场成长。

新冠疫情的影响：疫情导致面对面咨询减少，以及紧急监管审批的出台，加速了病理学领域数位转型。 2020 年 4 月，美国食品药物管理局 (FDA) 实施了一项政策，允许远端审查数位切片。 受远端病理学（远端病理诊断）和远端诊断技术广泛应用的推动，2020 年市场成长了 31.2%，高于 2019 年的 11.6%。儘管疫情消退后患者数量恢復到疫情前水平，但数位化解决方案的采用率仍然很高，支撑了市场成长动能。

人工智慧 (AI) 的整合：基于人工智慧的数位化工具正在透过实现高级影像分析、工作流程管理和基于深度学习的诊断来变革病理学。例如，罗氏于 2021 年 12 月发布了一种用于乳癌标记评估的人工智慧演算法，而 Sigtuple 的人工智慧辅助血液抹片检测应用于 2023 年 9 月获得了 FDA 的批准。这些进步提高了诊断准确性和营运效率。

市场限制因子

高昂的初始成本：实施一套数位病理系统，包括高通量扫描仪、软体和储存解决方案，需要大量的投资。 数位切片扫描器的价格从 10 万美元到 40 万美元不等，还不包括培训、技术支援和授权费用。小型实验室往往难以实施这些工具，从而限制了市场渗透率。此外，病理学家短缺——每 10 万人口净减少 5700 名病理学家——进一步阻碍了某些地区的普及。

市场区隔

依产品类型划分：

  • 硬体：到 2026 年，硬体将占 58.10% 的市场占有率，主要受对扫描仪和组织微阵列仪器的需求驱动，这些仪器可以加速病理诊断。
  • 软体：到 2024 年，软体将占 35.2% 的市场占有率，主要受对基于人工智慧的影像分析、病理管理和数位显微镜检视器的需求所驱动。
  • 储存系统：成长的驱动力是对安全资料储存和共享的需求。

依应用领域划分：

  • 疾病诊断：预计到 2026 年，该细分市场将占 54.96% 的市场占有率，主要受诊断检测需求增长和早期检测举措的推动。
  • 药物研发：高通量筛选与在研药物需求推动快速成长。

依最终使用者划分：

  • 医院和诊所：预计到 2026 年，该细分市场将占主导地位，市场占有率达到 62.18%，主要受患者数量增长和人工智慧辅助数位病理系统应用的推动。
  • 临床实验室：由于玻片数位化和人工智慧驱动的协作解决方案，该细分市场将实现成长。

区域洞察

北美：预计到 2025 年，市场规模将达到 4.8 亿美元，到 2026 年将达到 5 亿美元。主要驱动因素包括慢性病高发生率、人口老化以及工作流程日益数位化。

欧洲：第二大市场，受惠于技术进步、监管审批和人工智慧解决方案。预计到 2026 年，英国市场规模将达到 5,000 万美元，德国市场规模将达到 1.1 亿美元。

亚太地区：成长最快的地区，受益于医疗基础设施的不断完善、公共和私人投资的增加以及患者人数的增长。 预计到 2026 年，日本将达到 9,000 万美元，中国将达到 7,000 万美元，印度将达到 5,000 万美元。

拉丁美洲、中东和非洲：医疗旅游、医疗保健投资以及数位病理工具的采用预计将推动稳定成长。

主要公司与产业趋势

主要公司包括 F. Hoffmann-La Roche、Thermo Fisher Scientific、Hamamatsu Photonics、3DHISTECH、Philips、Apollo Enterprise Imaging、Sectra 和 Huron Technologies。

目录

第一章：引言

第二章：摘要整理

第三章：市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机遇
  • 市场趋势

第四章：关键考虑因素

  • 主要产业发展：併购与合作
  • 数位病理技术进步
  • 2024年全球数位健康市场概览
  • 新冠疫情对市场的影响

第五章：全球数位病理学市场分析、洞察与预测 2021-2034

  • 市场分析、洞察与预测：依产品分类
    • 硬体
      • 扫描仪
      • 组织微阵列设备
      • 其他
    • 软体
      • 病理管理
      • 数位显微镜观察器
      • 影像分析设备
      • 其他
    • 储存系统
  • 市场分析、洞察与预测：依应用分类
    • 疾病诊断
    • 药物研发
    • 其他
  • 市场分析、洞察与预测：依最终用户分类
    • 医院和诊所
    • 临床实验室
    • 其他
  • 市场分析、洞察与预测：依区域
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第六章：北美数位病理市场分析、洞察与预测（2021-2034）

  • 依国家划分
    • 美国
    • 加拿大

第七章：欧洲数位病理市场分析、洞察与预测（2021-2034）

  • 依国家划分
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 斯堪的纳维亚半岛
    • 欧洲其他地区

第八章：亚太数字病理市场分析、洞察与预测（2021-2034）

  • 依国家划分
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 东南亚
    • 亚太其他地区

第九章：拉丁美洲数位病理学市场分析、洞察与预测，2021–2034

  • 依国家划分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区

第十章：中东与非洲数位病理学市场分析、洞察与预测，2021–2034

  • 依国家划分
    • 海湾合作委员会国家
    • 南亚国家非洲
    • 中东和非洲其他地区

第十一章 竞争分析

  • 全球市占率分析（2024 年）
  • 公司简介
    • Leica Biosystems Nussloch GmbH
    • Thermo Fisher Scientific Inc.
    • F. Hoffmann-La Roche Ltd
    • Hamamatsu Photonics K.K.
    • Akoya Biosciences, Inc.
    • 3DHISTECH Ltd.
    • Koninklijke Philips N.V.
    • Apollo Enterprise Imaging Corp
    • Sectra AB
    • Huron Technologies International Inc.
Product Code: FBI100229

Growth Factors of digital pathology Market

The global digital pathology market is witnessing rapid growth, driven by the rising prevalence of chronic diseases, increased hospital admissions, and the growing adoption of digital tools in traditional pathology workflows. Digital pathology involves creating digital slides through whole-slide scanning devices or digital microscopes, which can then be analyzed using high-throughput algorithms, shared remotely, or stored for future reference. These innovations have transformed modern diagnostics, enabling faster and more accurate analysis while reducing workload for pathologists.

According to Fortune Business Insights, the market was valued at USD 1.3 billion in 2025, projected to grow to USD 1.47 billion in 2026, and estimated to reach USD 5.75 billion by 2034, reflecting a CAGR of 18.56% from 2026 to 2034. North America dominated the market in 2025 with a 36.74% share, led by robust digital infrastructure, early adoption of AI-powered pathology solutions, and high awareness of advanced diagnostics. In the U.S., the digital pathology market is projected to reach USD 1.30 billion by 2032, supported by increasing digitization and favorable FDA policies for remote review and analysis of digital slides.

Market Drivers

Rising Burden of Chronic Diseases: The increasing incidence of chronic conditions and hospitalizations is boosting demand for timely and accurate pathology tests. Studies indicate that digitization enhances efficiency, with pathologists reporting a 15% productivity increase compared to traditional workflows. Additionally, digital platforms are increasingly used for predictive analysis and early diagnosis of diseases, such as Parkinson's disease, further stimulating market growth.

COVID-19 Impact: The pandemic accelerated digital adoption in pathology due to reduced in-person consultations and emergency regulatory approvals. The U.S. FDA implemented policies in April 2020 allowing remote reviewing of digital slides. The market saw a 31.2% growth in 2020, compared to 11.6% in 2019, driven by telepathology and remote diagnostics. Post-pandemic, patient volumes returned to pre-pandemic levels, but adoption of digital solutions remained high, sustaining growth momentum.

Integration of Artificial Intelligence: AI-based digital tools are transforming pathology by enabling advanced image analysis, workflow management, and deep learning-based diagnostics. For example, Roche launched AI algorithms in December 2021 for breast cancer marker evaluation, and Sigtuple received FDA approval in September 2023 for its AI-assisted blood smear application. Such advancements improve diagnostic accuracy and operational efficiency.

Market Restraints

High Upfront Costs: The installation of digital pathology systems, including high-throughput scanners, software, and storage solutions, involves substantial investment. Digital slide scanners range from USD 100,000 to USD 400,000, excluding costs for training, technical support, and licensing. Smaller laboratories often struggle to afford these tools, which limits market penetration. Additionally, the shortage of pathologists, with a net deficit of 5,700 per 100,000 population, further hinders adoption in certain regions.

Market Segmentation

By Product Type:

  • Hardware: Dominates with 58.10% share in 2026, driven by demand for scanners and tissue microarrayers for timely pathology outcomes.
  • Software: Holds 35.2% share in 2024, fueled by AI-based image analysis, pathology management, and digital microscopy viewers.
  • Storage Systems: Supporting growth due to the need for secure data storage and sharing.

By Application:

  • Disease Diagnosis: Leading segment with 54.96% market share in 2026, driven by rising diagnostic testing requirements and early detection initiatives.
  • Drug Discovery: Growing rapidly due to high-throughput screening and demand for pipeline drugs.

By End User:

  • Hospitals & Clinics: Dominant with 62.18% share in 2026, supported by rising patient admissions and adoption of AI-assisted digital pathology systems.
  • Clinical Laboratories: Expanding segment due to digitization of slides and collaborative AI-driven solutions.

Regional Insights

North America: Market size USD 0.48 billion in 2025, projected at USD 0.5 billion by 2026, driven by high chronic disease prevalence, geriatric population, and workflow digitization initiatives.

Europe: Second-largest market, supported by technological advancements, regulatory approvals, and AI-based solutions. The UK market is projected at USD 0.05 billion by 2026, and Germany at USD 0.11 billion by 2026.

Asia Pacific: Fastest-growing region due to expanding healthcare infrastructure, public and private investments, and increasing patient volumes. Japan is projected at USD 0.09 billion, China at USD 0.07 billion, and India at USD 0.05 billion by 2026.

Latin America & Middle East & Africa: Steady growth is driven by medical tourism, healthcare investments, and adoption of digital pathology tools.

Key Players & Industry Developments

Prominent companies include F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Hamamatsu Photonics K.K., 3DHISTECH Ltd., Koninklijke Philips N.V., Apollo Enterprise Imaging Corp., Sectra AB, and Huron Technologies.

Recent Developments:

  • February 2024: Roche partnered with PathAI to develop AI algorithms for tissue diagnostics.
  • October 2023: Roche collaborated with Ibex and AWS for AI-enabled breast and prostate cancer diagnostics.
  • August 2023: PathAI launched AISight Digital Pathology Image Management System.
  • April 2022: 3DHISTECH deployed digital pathology tools across 8 hospitals in Spain.

Conclusion

The global digital pathology market is projected to grow from USD 1.3 billion in 2025 to USD 1.47 billion in 2026, reaching USD 5.75 billion by 2034 at a CAGR of 18.56%. Market growth is driven by increasing chronic disease burden, digitization of pathology workflows, integration of AI, and rising adoption of high-throughput diagnostic tools. Despite challenges like high upfront costs and shortage of pathologists, ongoing technological advancements, regulatory support, and strategic partnerships by key players are expected to sustain the market's robust growth globally.

Segmentation By Product

  • Hardware
    • Scanners
    • Tissue Microarrayer
    • Others
  • Software
    • Pathology Management
    • Digital Microscopy Viewers
    • Image Analyzers
    • Others
  • Storage Systems

By Application

  • Disease Diagnosis
  • Drug Discovery
  • Others

By End-user

  • Hospitals & Clinics
  • Clinical Laboratories
  • Others

By Geography

  • North America (By Product, Application, End-user, and Country)
    • U.S.
    • Canada
  • Europe (By Product, Application, End-user, and Country/Sub-Region)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Product, Application, End-user, and Country/Sub-Region)
    • China
    • India
    • Japan
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Product, Application, End-user, and Country/Sub-Region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Product, Application, End-user, and Country/Sub-Region)
    • GCC
    • South Africa
  • Rest of Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Key Industry Developments- Mergers, Acquisitions and Partnerships
  • 4.2. Technological Advancements in Digital Pathology
  • 4.3. Snapshot: Global Digital Health Market, 2024
  • 4.4. Impact of COVID-19 on the Market

5. Global Digital Pathology Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product
    • 5.1.1. Hardware
      • 5.1.1.1. Scanners
      • 5.1.1.2. Tissue Microarrayer
      • 5.1.1.3. Others
    • 5.1.2. Software
      • 5.1.2.1. Pathology Management
      • 5.1.2.2. Digital Microscopy Viewers
      • 5.1.2.3. Image Analyzers
      • 5.1.2.4. Others
    • 5.1.3. Storage Systems
  • 5.2. Market Analysis, Insights and Forecast - By Application
    • 5.2.1. Disease Diagnosis
    • 5.2.2. Drug Discovery
    • 5.2.3. Others
  • 5.3. Market Analysis, Insights and Forecast - By End User
    • 5.3.1. Hospitals & Clinics
    • 5.3.2. Clinical Laboratories
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Digital Pathology Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product
    • 6.1.1. Hardware
      • 6.1.1.1. Scanners
      • 6.1.1.2. Tissue Microarrayer
      • 6.1.1.3. Others
    • 6.1.2. Software
      • 6.1.2.1. Pathology Management
      • 6.1.2.2. Digital Microscopy Viewers
      • 6.1.2.3. Image Analyzers
      • 6.1.2.4. Others
    • 6.1.3. Storage Systems
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Disease Diagnosis
    • 6.2.2. Drug Discovery
    • 6.2.3. Others
  • 6.3. Market Analysis, Insights and Forecast - By End User
    • 6.3.1. Hospitals & Clinics
    • 6.3.2. Clinical Laboratories
    • 6.3.3. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Digital Pathology Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product
    • 7.1.1. Hardware
      • 7.1.1.1. Scanners
      • 7.1.1.2. Tissue Microarrayer
      • 7.1.1.3. Others
    • 7.1.2. Software
      • 7.1.2.1. Pathology Management
      • 7.1.2.2. Digital Microscopy Viewers
      • 7.1.2.3. Image Analyzers
      • 7.1.2.4. Others
    • 7.1.3. Storage Systems
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Disease Diagnosis
    • 7.2.2. Drug Discovery
    • 7.2.3. Others
  • 7.3. Market Analysis, Insights and Forecast - By End User
    • 7.3.1. Hospitals & Clinics
    • 7.3.2. Clinical Laboratories
    • 7.3.3. Others
  • 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 7.4.1. U.K.
    • 7.4.2. Germany
    • 7.4.3. France
    • 7.4.4. Spain
    • 7.4.5. Italy
    • 7.4.6. Scandinavia
    • 7.4.7. Rest of Europe

8. Asia Pacific Digital Pathology Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product
    • 8.1.1. Hardware
      • 8.1.1.1. Scanners
      • 8.1.1.2. Tissue Microarrayer
      • 8.1.1.3. Others
    • 8.1.2. Software
      • 8.1.2.1. Pathology Management
      • 8.1.2.2. Digital Microscopy Viewers
      • 8.1.2.3. Image Analyzers
      • 8.1.2.4. Others
    • 8.1.3. Storage Systems
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Disease Diagnosis
    • 8.2.2. Drug Discovery
    • 8.2.3. Others
  • 8.3. Market Analysis, Insights and Forecast - By End User
    • 8.3.1. Hospitals & Clinics
    • 8.3.2. Clinical Laboratories
    • 8.3.3. Others
  • 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 8.4.1. Japan
    • 8.4.2. China
    • 8.4.3. India
    • 8.4.4. Australia
    • 8.4.5. Southeast Asia
    • 8.4.6. Rest of Asia Pacific

9. Latin America Digital Pathology Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product
    • 9.1.1. Hardware
      • 9.1.1.1. Scanners
      • 9.1.1.2. Tissue Microarrayer
      • 9.1.1.3. Others
    • 9.1.2. Software
      • 9.1.2.1. Pathology Management
      • 9.1.2.2. Digital Microscopy Viewers
      • 9.1.2.3. Image Analyzers
      • 9.1.2.4. Others
    • 9.1.3. Storage Systems
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Disease Diagnosis
    • 9.2.2. Drug Discovery
    • 9.2.3. Others
  • 9.3. Market Analysis, Insights and Forecast - By End User
    • 9.3.1. Hospitals & Clinics
    • 9.3.2. Clinical Laboratories
    • 9.3.3. Others
  • 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America

10. Middle East & Africa Digital Pathology Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Product
    • 10.1.1. Hardware
      • 10.1.1.1. Scanners
      • 10.1.1.2. Tissue Microarrayer
      • 10.1.1.3. Others
    • 10.1.2. Software
      • 10.1.2.1. Pathology Management
      • 10.1.2.2. Digital Microscopy Viewers
      • 10.1.2.3. Image Analyzers
      • 10.1.2.4. Others
    • 10.1.3. Storage Systems
  • 10.2. Market Analysis, Insights and Forecast - By Application
    • 10.2.1. Disease Diagnosis
    • 10.2.2. Drug Discovery
    • 10.2.3. Others
  • 10.3. Market Analysis, Insights and Forecast - By End User
    • 10.3.1. Hospitals & Clinics
    • 10.3.2. Clinical Laboratories
    • 10.3.3. Others
  • 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 10.4.1. GCC Countries
    • 10.4.2. South Africa
    • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2024)
  • 11.2. Company Profiles
    • 11.2.1. Leica Biosystems Nussloch GmbH
      • 11.2.1.1. Overview
      • 11.2.1.2. Products
      • 11.2.1.3. SWOT analysis
      • 11.2.1.4. Recent developments
      • 11.2.1.5. strategies
      • 11.2.1.6. financials (based on availability)
    • 11.2.2. Thermo Fisher Scientific Inc.
      • 11.2.2.1. Overview
      • 11.2.2.2. Products
      • 11.2.2.3. SWOT analysis
      • 11.2.2.4. Recent developments
      • 11.2.2.5. strategies
      • 11.2.2.6. financials (based on availability)
    • 11.2.3. F. Hoffmann-La Roche Ltd
      • 11.2.3.1. Overview
      • 11.2.3.2. Products
      • 11.2.3.3. SWOT analysis
      • 11.2.3.4. Recent developments
      • 11.2.3.5. strategies
      • 11.2.3.6. financials (based on availability)
    • 11.2.4. Hamamatsu Photonics K.K.
      • 11.2.4.1. Overview
      • 11.2.4.2. Products
      • 11.2.4.3. SWOT analysis
      • 11.2.4.4. Recent developments
      • 11.2.4.5. strategies
      • 11.2.4.6. financials (based on availability)
    • 11.2.5. Akoya Biosciences, Inc.
      • 11.2.5.1. Overview
      • 11.2.5.2. Products
      • 11.2.5.3. SWOT analysis
      • 11.2.5.4. Recent developments
      • 11.2.5.5. strategies
      • 11.2.5.6. financials (based on availability)
    • 11.2.6. 3DHISTECH Ltd.
      • 11.2.6.1. Overview
      • 11.2.6.2. Products
      • 11.2.6.3. SWOT analysis
      • 11.2.6.4. Recent developments
      • 11.2.6.5. strategies
      • 11.2.6.6. financials (based on availability)
    • 11.2.7. Koninklijke Philips N.V.
      • 11.2.7.1. Overview
      • 11.2.7.2. Products
      • 11.2.7.3. SWOT analysis
      • 11.2.7.4. Recent developments
      • 11.2.7.5. strategies
      • 11.2.7.6. financials (based on availability)
    • 11.2.8. Apollo Enterprise Imaging Corp
      • 11.2.8.1. Overview
      • 11.2.8.2. Products
      • 11.2.8.3. SWOT analysis
      • 11.2.8.4. Recent developments
      • 11.2.8.5. strategies
      • 11.2.8.6. financials (based on availability)
    • 11.2.9. Sectra AB
      • 11.2.9.1. Overview
      • 11.2.9.2. Products
      • 11.2.9.3. SWOT analysis
      • 11.2.9.4. Recent developments
      • 11.2.9.5. strategies
      • 11.2.9.6. financials (based on availability)
    • 11.2.10. Huron Technologies International Inc.
      • 11.2.10.1. Overview
      • 11.2.10.2. Products
      • 11.2.10.3. SWOT analysis
      • 11.2.10.4. Recent developments
      • 11.2.10.5. strategies
      • 11.2.10.6. financials (based on availability)

List of Tables

  • Table 1: Global Digital Pathology Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 2: Global Digital Pathology Market Revenue (USD billion) Forecast, by Hardware, 2021-2034
  • Table 3: Global Digital Pathology Market Revenue (USD billion) Forecast, by Software, 2021-2034
  • Table 4: Global Digital Pathology Market Revenue (USD billion) Forecast, by Applications, 2021-2034
  • Table 5: Global Digital Pathology Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 6: Global Digital Pathology Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 7: North America Digital Pathology Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 8: North America Digital Pathology Market Revenue (USD billion) Forecast, by Hardware, 2021-2034
  • Table 9: North America Digital Pathology Market Revenue (USD billion) Forecast, by Software, 2021-2034
  • Table 10: North America Digital Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 11: North America Digital Pathology Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 12: North America Digital Pathology Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 13: Europe Digital Pathology Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 14: Europe Digital Pathology Market Revenue (USD billion) Forecast, by Hardware, 2021-2034
  • Table 15: Europe Digital Pathology Market Revenue (USD billion) Forecast, by Software, 2021-2034
  • Table 16: Europe Digital Pathology Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 17: Europe Digital Pathology Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 18: Asia Pacific Digital Pathology Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 19: Asia Pacific Digital Pathology Market Revenue (USD billion) Forecast, by Hardware, 2021-2034
  • Table 20: Asia Pacific Digital Pathology Market Revenue (USD billion) Forecast, by Software, 2021-2034
  • Table 21: Asia Pacific Digital Pathology Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 22: Asia Pacific Digital Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 23: Asia Pacific Digital Pathology Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 24: Latin America Digital Pathology Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 25: Latin America Digital Pathology Market Revenue (USD billion) Forecast, by Hardware, 2021-2034
  • Table 26: Latin America Digital Pathology Market Revenue (USD billion) Forecast, by Software, 2021-2034
  • Table 27: Latin America Digital Pathology Market Revenue (USD billion) Forecast, by Applications, 2021-2034
  • Table 28: Latin America Digital Pathology Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 29: Latin America Digital Pathology Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 30: Middle East & Africa Digital Pathology Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 31: Middle East & Africa Digital Pathology Market Revenue (USD billion) Forecast, by Hardware, 2021-2034
  • Table 32: Middle East & Africa Digital Pathology Market Revenue (USD billion) Forecast, by Software, 2021-2034
  • Table 33: Middle East & Africa Digital Pathology Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 34: Middle East & Africa Digital Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 35: Middle East & Africa Digital Pathology Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Digital Pathology Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Digital Pathology Market Value Share (%), by Product, 2025 & 2034
  • Figure 3: Global Digital Pathology Market Value Share (%), by Application, 2025 & 2034
  • Figure 4: Global Digital Pathology Market Value Share (%), by End-user, 2025 & 2034
  • Figure 5: Global Digital Pathology Market Value (USD billion), by Region, 2025 & 2034
  • Figure 6: North America Digital Pathology Market Value (USD billion), by Product, 2025 & 2034
  • Figure 7: North America Digital Pathology Market Value Share (%), by Product, 2024
  • Figure 8: North America Digital Pathology Market Value (USD billion), by Application, 2025 & 2034
  • Figure 9: North America Digital Pathology Market Value Share (%), by Application, 2024
  • Figure 10: North America Digital Pathology Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 11: North America Digital Pathology Market Value Share (%), by End-user, 2024
  • Figure 12: North America Digital Pathology Market Value (USD billion), By Country, 2025 & 2034
  • Figure 13: North America Digital Pathology Market Value Share (%), By Country, 2024
  • Figure 14: Europe Digital Pathology Market Value (USD billion), by Product, 2025 & 2034
  • Figure 15: Europe Digital Pathology Market Value Share (%), by Product, 2024
  • Figure 16: Europe Digital Pathology Market Value (USD billion), by Application, 2025 & 2034
  • Figure 17: Europe Digital Pathology Market Value Share (%), by Application, 2024
  • Figure 18: Europe Digital Pathology Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 19: Europe Digital Pathology Market Value Share (%), by End-user, 2024
  • Figure 20: Europe Digital Pathology Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 21: Europe Digital Pathology Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 22: Asia Pacific Digital Pathology Market Value (USD billion), by Product, 2025 & 2034
  • Figure 23: Asia Pacific Digital Pathology Market Value Share (%), by Product, 2024
  • Figure 24: Asia Pacific Digital Pathology Market Value (USD billion), by Application, 2025 & 2034
  • Figure 25: Asia Pacific Digital Pathology Market Value Share (%), by Application, 2024
  • Figure 26: Asia Pacific Digital Pathology Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 27: Asia Pacific Digital Pathology Market Value Share (%), by End-user, 2024
  • Figure 28: Asia Pacific Digital Pathology Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 29: Asia Pacific Digital Pathology Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 30: Latin America Digital Pathology Market Value (USD billion), by Product, 2025 & 2034
  • Figure 31: Latin America Digital Pathology Market Value Share (%), by Product, 2024
  • Figure 32: Latin America Digital Pathology Market Value (USD billion), by Application, 2025 & 2034
  • Figure 33: Latin America Digital Pathology Market Value Share (%), by Application, 2024
  • Figure 34: Latin America Digital Pathology Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 35: Latin America Digital Pathology Market Value Share (%), by End-user, 2024
  • Figure 36: Latin America Digital Pathology Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 37: Latin America Digital Pathology Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 38: Middle East & Africa Digital Pathology Market Value (USD billion), by Product, 2025 & 2034
  • Figure 39: Middle East & Africa Digital Pathology Market Value Share (%), by Product, 2024
  • Figure 40: Middle East & Africa Digital Pathology Market Value (USD billion), by Application, 2025 & 2034
  • Figure 41: Middle East & Africa Digital Pathology Market Value Share (%), by Application, 2024
  • Figure 42: Middle East & Africa Digital Pathology Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 43: Middle East & Africa Digital Pathology Market Value Share (%), by End-user, 2024
  • Figure 44: Middle East & Africa Digital Pathology Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 45: Middle East & Africa Digital Pathology Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 46: Global Digital Pathology Market Share (%), By Company, 2024